Skip to content
Already a leader in biotech for agriculture, Bayer announced plans to double its Crop Sciences Division with a major push into regenerative farming. Along […]
Bayer digs into regenerative farming through biotech Read More »
Heart disease remains the leading cause of death in the United States. According to the American Heart Association (AHA), in 2020, cardiovascular disease (CVD)
In a big week for reauthorization of the Pandemic All Hazards and Preparedness Act (PAHPA), versions of the legislation were approved by a House
PAHPA legislation moves forward in Senate and House Read More »
With over 6 million unintended pregnancies in the U.S. each year and birth rates on the rise since 2021, making it easy to obtain
FDA approves first over-the-counter birth control pill Read More »
We see a great demand for effective therapies, particularly for conditions with limited treatment options. Transformative treatments, no matter how small, have the impact
3 things to know about the future of small molecule therapeutics Read More »
On July 17, Eli Lilly announced positive results from clinical trials of donanemab, the company’s candidate for the treatment of Alzheimer’s disease. The drug
Eli Lilly’s Alzheimer’s drug shows promise in slowing cognitive decline Read More »
In the latest bioscience victory over viruses, the Food and Drug Administration (FDA) on July 17 gave the first approval to a monoclonal antibody
FDA approves monoclonal antibody to protect infants from RSV Read More »
The Inflation Reduction Act has brought sustainable aviation fuels (SAFs) into the spotlight. Aviation accounts for over 2% of global greenhouse gas emissions, and
Q&A: How Gevo’s ETO technology aims to make aviation more sustainable Read More »
According to the European Innovative ScoreBoard (EIS), the level of innovation in a country is particularly relevant for life sciences companies when choosing a
Western Switzerland: Collaboration is the key to a robust life sciences sector Read More »
The challenge of preventing pharmacy benefit managers (PBMs) from driving up drug prices was front and center on Capitol Hill this week. Bipartisan legislation
Congress puts PBMs in the spotlight during a busy week on Capitol Hill Read More »
